Orthopoxvirus and Monkeypox Coding and Guidance
Date Posted: Thursday,
September 15, 2022
New Current Procedural Terminology (CPT®) codes have been created that streamline the reporting of orthopoxvirus and monkeypox testing and immunizations currently available on the United States market.
Category I and Pathology and Laboratory/Microbiology
The CPT Editorial Panel has approved the addition of code 87593 to report orthopoxvirus detection by nucleic acid using amplified probe technique.
87593: Infectious agent detection by nucleic acid (DNA or RNA); orthopoxvirus (e.g., monkeypox virus, cowpox virus, vaccinia virus), amplified probe technique, each.
Unique CPT Codes Approved for Smallpox and Monkeypox Immunizations
The CPT Editorial Panel has approved the addition of code 90622 to identify vaccinia (smallpox) virus vaccine product, and addition of code 90611 to identify monkeypox and smallpox virus vaccine product.
90611: Smallpox and monkeypox vaccine, attenuated vaccinia virus, live, non-replicating, preservative free, 0.5 ml dosage, suspension, for subcutaneous use.
90622: Vaccinia (smallpox) virus vaccine, live, lyophilized, 0.3 ml dosage, for percutaneous use.